We are live on
!
Find out more
MAM
Melqart Asset Management Portfolio holdings
AUM
$1.01B
1-Year Est. Return
84.85%
This Fund
S&P 500
This Quarter
Est. Return
+7.18%
1 Year Est. Return
+84.85%
3 Year Est. Return
+183.09%
5 Year Est. Return
+319.83%
10 Year Est. Return
–
AUM
$1.1B
AUM Growth
-$353M
(-24%)
Cap. Flow
-$395M
Cap. Flow
% of AUM
-35.87%
Top 10 Holdings %
Top 10 Hldgs %
70.73%
Holding
40
New
9
Increased
8
Reduced
7
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$53.9M |
| 2 |
CY
Cypress Semiconductor
CY
|
+$41.7M |
| 3 |
ALDR
Alder Biopharmaceuticals
ALDR
|
+$30.7M |
| 4 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$26.6M |
| 5 |
ACIA
Acacia Communications Inc
ACIA
|
+$26.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RHT
Red Hat Inc
RHT
|
+$118M |
| 2 |
APC
Anadarko Petroleum
APC
|
+$111M |
| 3 |
ARRY
Array Biopharma Inc
ARRY
|
+$59.4M |
| 4 |
FDC
First Data Corporation
FDC
|
+$39.5M |
| 5 |
Tesla
TSLA
|
+$35.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.88% |
| 2 | Healthcare | 32.57% |
| 3 | Materials | 5.67% |
| 4 | Industrials | 5.32% |
| 5 | Consumer Discretionary | 4.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
1
DELISTED
Celgene Corp
CELG
| $144M | 13.08% |
1,451,000
+15,000
| +1% | +$1.43M |
|
2
NXP Semiconductors
NXPI
$68B
| $115M | 10.41% |
1,050,000
-108,000
| -9% | -$11M |
|
|
AGN
3
DELISTED
Allergan plc
AGN
| $102M | 9.3% |
608,700
+330,700
| +119% | +$53.9M |
|
|
CY
4
DELISTED
Cypress Semiconductor
CY
| $89.2M | 8.1% |
3,823,000
+1,823,000
| +91% | +$41.7M |
|
|
ZAYO
5
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $74.6M | 6.78% |
2,201,000
+401,000
| +22% | +$13.5M |
|
|
MLNX
6
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $68.9M | 6.25% |
628,391
+89,500
| +17% | +$9.88M |
|
|
WBC
7
DELISTED
WABCO HOLDINGS INC.
WBC
| $51.2M | 4.65% |
383,000
-70,500
| -16% | -$9.38M |
|
|
ALDR
8
DELISTED
Alder Biopharmaceuticals
ALDR
| $50.5M | 4.59% |
+2,680,000
| New | +$30.7M |
|
|
VSM
9
DELISTED
Versum Materials, Inc.
VSM
| $47.1M | 4.28% |
890,000
-269,000
| -23% | -$14M |
|
|
NLSN
10
DELISTED
Nielsen Holdings plc
NLSN
| $36.1M | 3.28% |
1,701,161
-75,762
| -4% | -$1.67M |
|
|
AVYA
11
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $35.9M | 3.26% |
3,512,988
+1,300,215
| +59% | +$15.3M |
|
|
CONE
12
DELISTED
CyrusOne Inc Common Stock
CONE
| $31.5M | 2.86% |
+398,600
| New | +$26.6M |
|
13
Takeda Pharmaceutical
TAK
$55.1B
| $28.8M | 2.61% |
1,672,350
+32,350
| +2% | +$559K |
|
|
I
14
CALL
DELISTED
INTELSAT S. A.
I
| $28.1M | 2.55% |
1,231,500
| – | – |
|
|
ACIA
15
DELISTED
Acacia Communications Inc
ACIA
| $27.1M | 2.46% |
+414,579
| New | +$26.2M |
|
16
Vertex Pharmaceuticals
VRTX
$121B
| $27.1M | 2.46% |
160,000
+16,000
| +11% | +$2.83M |
|
|
PSDO
17
DELISTED
Presidio, Inc. Common Stock
PSDO
| $24.6M | 2.24% |
+1,457,155
| New | +$21.7M |
|
|
QIWI
18
DELISTED
QIWI PLC
QIWI
| $22.5M | 2.04% |
1,023,639
-1,057,391
| -51% | -$22.8M |
|
|
AY
19
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $21M | 1.9% |
869,936
-604,679
| -41% | -$14.2M |
|
20
Alpha Metallurgical Resources
AMR
$1.82B
| $15.4M | 1.39% |
549,115
-145,734
| -21% | -$5.07M |
|
21
Atlassian
TEAM
$22B
| $13.4M | 1.22% |
+107,000
| New | +$14.6M |
|
22
Twilio
TWLO
$29.1B
| $13.2M | 1.2% |
+120,000
| New | +$15.6M |
|
23
RingCentral
RNG
$4.05B
| $13M | 1.18% |
+103,234
| New | +$13.5M |
|
|
QES
24
DELISTED
Quintana Energy Services Inc.
QES
| $6.71M | 0.61% |
3,288,449
| – | – |
|
25
FIVE9
FIVN
$1.77B
| $6.18M | 0.56% |
+115,000
| New | +$6.47M |
|
Similar funds
LPAM
WA
COI
GA
AG
BCM
EPAM
MCM
Melqart Asset Management's Q3 2019 Portfolio in Review
As of Q3 2019, Melqart Asset Management held 40 positions worth $1.1B, down 24% from $1.45B the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Melqart Asset Management withdrew a net $395M in Q3 2019, closing 13 positions and reducing 7 holdings. Its most notable exit was Red Hat Inc, an estimated $118M position sold in full.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 20% a quarter earlier, followed by Healthcare and Materials.
Against the trend, Melqart Asset Management opened a new position in Alder Biopharmaceuticals worth $50.5M.
- Melqart Asset Management's largest Q3 2019 buy was Alder Biopharmaceuticals: 2,680,000 shares worth $50.5M.
- Melqart Asset Management added most to Allergan plc in Q3 2019, an estimated $53.9M increase.
- Melqart Asset Management's biggest Q3 2019 reduction was QIWI PLC, cutting an estimated $22.8M.
- Melqart Asset Management fully exited Red Hat Inc in Q3 2019, selling an estimated $118M.
- Melqart Asset Management's ten largest holdings make up 71% of its $1.1B portfolio in Q3 2019.
- Melqart Asset Management opened 9 new positions and closed 13 in Q3 2019.
- Melqart Asset Management's portfolio value fell 24% quarter-over-quarter to $1.1B.
Based on Melqart Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.